Collaboration to Commercialise Specialised MAT Reagents for in vitro Pyrogen Testing Announced

摘要

Lonza Sales AG, through its Bioscience Division, and Sanquin Reagents BV have entered into a strategic partnership for the commercialisation of a range of specialised reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test (MAT). This partnership expands Lonza's extensive portfolio of endotoxin testing products, and enables drug developers and quality control (QC) laboratories to explore the full potential of the high-performing, sustainable MAT method to bring safe pharmaceuticals to the market.